# Zavesca

NDC: 66215-201
Generic name: miglustat
Labeler / Manufacturer: Actelion Pharmaceuticals US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20030731

FDA application: NDA021348

## Active ingredients

- MIGLUSTAT: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66215-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66215-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=817892d1-ee12-4632-85fc-57ccdf16d7b8